Caribou Biosciences, Inc.
CRBU
$1.44
-$0.10-6.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.28M | -25.09M | -26.49M | -27.55M | -54.10M |
| Total Depreciation and Amortization | 625.00K | 649.00K | 682.00K | 631.00K | 1.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75M | 2.40M | 3.12M | 3.14M | 24.12M |
| Change in Net Operating Assets | -1.88M | -4.95M | 1.87M | -1.41M | 554.00K |
| Cash from Operations | -22.79M | -26.98M | -20.82M | -25.19M | -28.26M |
| Capital Expenditure | -1.00K | -72.00K | 216.00K | -115.00K | -418.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.94M | 24.06M | 17.75M | 10.97M | 24.45M |
| Cash from Investing | 18.94M | 23.99M | 17.97M | 10.85M | 24.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.94M | 2.70M | 4.07M | 277.00K | 6.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 17.94M | 2.70M | 4.07M | 277.00K | 6.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.09M | -303.00K | 1.22M | -14.06M | -4.22M |